We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.86B
Cap. Flow %
-7.46%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEO icon
3601
PUT
American Eagle Outfitters
AEO
$2.98B
$386K ﹤0.01%
27,500
-49,600
-64% -$737K
BC icon
3602
PUT
Brunswick
BC
$5.25B
$386K ﹤0.01%
6,300
-3,200
-34% -$189K
IVZ icon
3603
PUT
Invesco
IVZ
$14B
$386K ﹤0.01%
12,600
-19,700
-61% -$616K
FFIV icon
3604
CALL
F5
FFIV
$23.4B
$385K ﹤0.01%
2,700
-9,400
-78% -$1.34M
SRG
3605
Seritage Growth Properties
SRG
$136M
$385K ﹤0.01%
8,926
+4,597
+106% +$200K
PRTK
3606
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$385K ﹤0.01%
20,000
MAS icon
3607
CALL
Masco
MAS
$14.8B
$384K ﹤0.01%
11,300
+1,300
+13% +$43.4K
EZU icon
3608
iShare MSCI Eurozone ETF
EZU
$9.83B
$383K ﹤0.01%
10,191
-3,472
-25% -$125K
FBIN icon
3609
CALL
Fortune Brands Innovations
FBIN
$5.98B
$383K ﹤0.01%
7,371
+5,967
+425% +$293K
PPBI
3610
DELISTED
Pacific Premier Bancorp
PPBI
$383K ﹤0.01%
9,917
+5,185
+110% +$199K
VVX icon
3611
V2X
VVX
$2.66B
$382K ﹤0.01%
17,107
+15,673
+1,093% +$360K
CEMP
3612
DELISTED
Cempra, Inc.
CEMP
$382K ﹤0.01%
101,532
-101,397
-50% -$352K
SWC
3613
PUT
DELISTED
Stillwater Mining Co
SWC
$382K ﹤0.01%
22,100
-20,600
-48% -$352K
COTY icon
3614
CALL
Coty
COTY
$2.37B
$381K ﹤0.01%
21,000
+9,800
+88% +$185K
ING icon
3615
ING
ING
$102B
$381K ﹤0.01%
25,240
-34,040
-57% -$499K
MRC
3616
DELISTED
MRC Global
MRC
$381K ﹤0.01%
20,730
+7,097
+52% +$141K
IDTI
3617
CALL
DELISTED
Integrated Device Technology I
IDTI
$381K ﹤0.01%
16,100
-134,500
-89% -$3.3M
EMN icon
3618
CALL
Eastman Chemical
EMN
$8.41B
$380K ﹤0.01%
4,700
-3,100
-40% -$244K
LPX icon
3619
PUT
Louisiana-Pacific
LPX
$5.21B
$380K ﹤0.01%
15,300
+14,100
+1,175% +$312K
CHRW icon
3620
PUT
C.H. Robinson
CHRW
$17.2B
$379K ﹤0.01%
4,900
+600
+14% +$46.1K
TFCFA
3621
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$379K ﹤0.01%
11,700
-41,800
-78% -$1.28M
EQGP
3622
DELISTED
EQGP Holdings, LP
EQGP
$379K ﹤0.01%
13,816
-6,123
-31% -$167K
AG icon
3623
PUT
First Majestic Silver
AG
$8.55B
$378K ﹤0.01%
46,500
-23,600
-34% -$210K
HUBS icon
3624
HubSpot
HUBS
$10B
$378K ﹤0.01%
6,236
-3,169
-34% -$180K
PCAR icon
3625
PUT
PACCAR
PCAR
$69.5B
$376K ﹤0.01%
8,400
+2,100
+33% +$94.6K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.